Plasma metabolites associated with type 2 diabetes in a Swedish population: a case–control study nested in a prospective cohort

Abstract

Predictive metabolites may improve understanding of the pathophysiology of type 2 diabetes and reflect disease progression, but they provide limited incremental value in risk prediction beyond optimal use of traditional risk factors.